Loading...

Imatinib sensitivity in BCR-ABL1-positive chronic myeloid leukemia cells is regulated by the remaining normal ABL1 allele

Chronic myeloid leukemia in chronic phase (CML-CP) cells that harbor oncogenic BCR-ABL1 and normal ABL1 allele often become resistant to the ABL1 kinase inhibitor imatinib. Here we report that loss of the remaining normal ABL1 allele in these tumors, which results from cryptic interstitial deletion...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Virgili, Anna, Koptyra, Mateusz, Dasgupta, Yashodhara, Glodkowska-Mrowka, Eliza, Stoklosa, Tomasz, Nacheva, Elisabeth P., Skorski, Tomasz
Format: Artigo
Sprog:Inglês
Udgivet: 2011
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3156347/
https://ncbi.nlm.nih.gov/pubmed/21693657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-11-0068
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!